Immediate Impact
4 by Nobel laureates 5 from Science/Nature 52 standout
Citing Papers
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Works of K A Kirchner being referenced
Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| K A Kirchner | 256 | 189 | 168 | 194 | 32 | 752 | |
| Peter Morsing | 362 | 185 | 124 | 182 | 36 | 767 | |
| I. Antonipillai | 312 | 102 | 148 | 310 | 34 | 938 | |
| Shahla Riazi | 328 | 155 | 116 | 280 | 21 | 707 | |
| Gloria Rashid | 175 | 110 | 280 | 138 | 38 | 988 | |
| Bartter Fc | 146 | 163 | 193 | 141 | 32 | 672 | |
| Ali A. Khraibi | 213 | 110 | 141 | 131 | 51 | 846 | |
| Shozo Torikai | 323 | 164 | 138 | 130 | 25 | 720 | |
| F. Krück | 227 | 207 | 123 | 185 | 60 | 783 | |
| M. Hermle | 227 | 137 | 222 | 103 | 23 | 740 | |
| J. C. Pelayo | 239 | 127 | 167 | 128 | 19 | 778 |
All Works
Loading papers...